Royce & Associates LP lessened its position in Sapiens International Co. (NASDAQ:SPNS - Free Report) by 20.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 562,756 shares of the technology company's stock after selling 143,289 shares during the period. Royce & Associates LP owned approximately 1.01% of Sapiens International worth $20,974,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Summit Securities Group LLC acquired a new stake in Sapiens International in the second quarter valued at about $34,000. Financial Management Professionals Inc. boosted its stake in shares of Sapiens International by 57.9% in the third quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company's stock valued at $72,000 after buying an additional 713 shares in the last quarter. Morgan Dempsey Capital Management LLC grew its holdings in Sapiens International by 9.5% during the second quarter. Morgan Dempsey Capital Management LLC now owns 4,206 shares of the technology company's stock worth $143,000 after acquiring an additional 365 shares during the period. Lazard Asset Management LLC purchased a new position in Sapiens International in the first quarter worth $192,000. Finally, MQS Management LLC acquired a new stake in Sapiens International in the third quarter valued at $230,000. Hedge funds and other institutional investors own 30.73% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on SPNS shares. Needham & Company LLC cut their price target on shares of Sapiens International from $44.00 to $35.00 and set a "buy" rating for the company in a report on Tuesday. StockNews.com raised shares of Sapiens International from a "buy" rating to a "strong-buy" rating in a report on Monday, November 11th. Barclays decreased their price target on Sapiens International from $38.00 to $30.00 and set an "underweight" rating on the stock in a research note on Tuesday. Finally, The Goldman Sachs Group upped their price target on Sapiens International from $38.00 to $43.00 and gave the stock a "buy" rating in a report on Friday, August 2nd.
Check Out Our Latest Research Report on Sapiens International
Sapiens International Price Performance
Shares of NASDAQ SPNS traded down $0.56 on Friday, hitting $28.00. The company's stock had a trading volume of 190,791 shares, compared to its average volume of 129,784. The stock has a 50 day moving average of $35.79 and a 200-day moving average of $35.34. The company has a market capitalization of $1.56 billion, a price-to-earnings ratio of 22.05 and a beta of 1.25. Sapiens International Co. has a 12-month low of $25.00 and a 12-month high of $41.22. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.18 and a quick ratio of 2.16.
Sapiens International (NASDAQ:SPNS - Get Free Report) last posted its earnings results on Monday, November 11th. The technology company reported $0.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.38 by ($0.01). The company had revenue of $137.00 million during the quarter, compared to analysts' expectations of $140.10 million. Sapiens International had a net margin of 13.23% and a return on equity of 17.61%. Sapiens International's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.32 EPS. As a group, research analysts predict that Sapiens International Co. will post 1.42 EPS for the current year.
Sapiens International Profile
(
Free Report)
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.
Featured Articles
Before you consider Sapiens International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sapiens International wasn't on the list.
While Sapiens International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.